death from semaglutide The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications semaglutide death rate Patients with

Chemical changes can take place within medication, which can lead to unexpected side effects or adverse reactions

This mechanism has led to NICE recommendations for certain GLP-1 receptor agonists for weight management in individuals with obesity, even without diabetes

If youve had issues with weight loss medications previously, our team will evaluate your medical history and explore alternative solutions tailored to your needs.

GLP-1 medicines act on hormone pathways involved in appetite, fullness, food intake and glucose regulation

As of 2023, there are no peer-reviewed, randomised controlled trials published in reputable medical journals that demonstrate berberine patches achieve clinically meaningful systemic absorption or produce therapeutic effects comparable to oral formulations